ISIS PHARMACEUTICALS INC's ticker is ISIS and the CUSIP is 464330109. A total of 172 filers reported holding ISIS PHARMACEUTICALS INC in Q2 2013. The put-call ratio across all filers is 0.88 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2015 | $38,801,000 | -15.5% | 959,952 | +20.3% | 0.03% | -13.2% |
| Q2 2015 | $45,922,000 | -31.4% | 797,958 | -24.1% | 0.04% | -29.6% |
| Q1 2015 | $66,895,000 | +18.5% | 1,050,658 | +14.9% | 0.05% | +14.9% |
| Q4 2014 | $56,464,000 | +49.9% | 914,542 | -5.7% | 0.05% | +46.9% |
| Q3 2014 | $37,656,000 | -1.3% | 969,767 | -12.4% | 0.03% | 0.0% |
| Q2 2014 | $38,154,000 | -22.6% | 1,107,527 | -2.9% | 0.03% | -25.6% |
| Q1 2014 | $49,296,000 | +10.9% | 1,140,853 | +2.2% | 0.04% | +7.5% |
| Q4 2013 | $44,453,000 | -19.6% | 1,115,777 | -24.2% | 0.04% | -27.3% |
| Q3 2013 | $55,280,000 | +42.2% | 1,472,554 | +1.8% | 0.06% | +34.1% |
| Q2 2013 | $38,864,000 | – | 1,446,363 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BB BIOTECH AG | 7,202,585 | $270,385,000 | 14.71% |
| DOWLING & YAHNKE LLC | 675,798 | $25,369,000 | 3.98% |
| GARRISON BRADFORD & ASSOCIATES INC | 100,700 | $3,780,000 | 3.87% |
| WILLIAM HARRIS INVESTORS INC | 312,834 | $11,743,000 | 3.67% |
| Meditor Group Ltd | 490,000 | $18,395,000 | 2.59% |
| AVALON CAPITAL MANAGEMENT | 50,943 | $1,912,000 | 1.89% |
| Orinda Asset Management LLC | 14,665 | $551,000 | 1.73% |
| PINNACLE ASSOCIATES LTD | 2,064,760 | $77,511,000 | 1.60% |
| PERKINS CAPITAL MANAGEMENT INC | 52,850 | $1,984,000 | 1.43% |
| NCM Capital Advisers, Inc. | 24,950 | $937,000 | 1.04% |